NVO
USDNovo Nordisk A/S Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$46.220
उच्च
$46.360
कम
$45.570
मात्रा
37.86M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
210.1B
उद्योग
Drug Manufacturers - General
देश
Denmark
ट्रेडिंग आँकड़े
औसत मात्रा
15.16M
एक्सचेंज
NYQ
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.
November trading, Berkshire's cash hoard, Big Tech's ad revenue and more in Morning Squawk
Here are five key things investors need to know to start the trading day.
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound
Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.
संबंधित स्टॉक
STRRP
Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock
GOSS
Gossamer Bio Inc.
RGLS
Regulus Therapeutics Inc.
LEXX
Lexaria Bioscience Corp.
OMGA
Omega Therapeutics Inc.
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।